CannaPharmaRx

CannaPharmaRx within the healthcare community as a global leader in Endocannabinoid system (eCS) research & development

The marketplace for cannabis-based products is rapidly undergoing metamorphosis. From its longstanding position as a $30-50 billion dollar illegal U.S. industry at the federal and state levels, it is now a state-regulated (still federally illegal) $2.53 billion industry. Projected sales growth is 700% over the next five years, making it the fastest growing industry in the US. More than 20 states have adopted medical or adult use legislations, with 14 more states expected to follow suit in the next 18 months.